OPEN END-TURBO-OPTIONSSCHEIN - AMGEN | Market Closed - BOERSE MUENCHEN 15:36:23 2024-07-15 EDT | ||
| 0.75 EUR | -2.60% |
|
| Current month | +25.00% | ||
| 1 month | +56.25% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-07-15 | 0.75 | -2.60% |
| 24-07-12 | 0.77 | +8.45% |
| 24-07-11 | 0.71 | +7.58% |
| 24-07-10 | 0.66 | +10.00% |
| 24-07-09 | 0.6 | +3.45% |
Real-time BOERSE MUENCHEN
Last update July 15, 2024 at 03:36 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | HSBC |
| WKN | HS1L9Z |
| ISIN | DE000HS1L9Z5 |
| Date issued | 2023-08-29 |
| Strike | 250.3 $ |
| Maturity | Unlimited |
| Parity | 100 : 1 |
| Emission price | 0.21 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.78 € |
|---|---|
| Lowest since issue | 0.13 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
330.2
USD
Average target price
317.4
USD
Spread / Average Target
-3.86%
- Stock Market
- Certificates
- Certificat
